Coya Therapeutics annual current ratio
2021
2022
2023
2024
2025
Coya Therapeutics Current Ratio Growth & History (COYA)
Coya Therapeutics's current ratio was 8.50 for fiscal 2025.
View full Coya Therapeutics company overviewCoya Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 8.50 | −3.08 | −26.59% |
| 2024 | 2024-12-31 | 11.59 | 3.43 | +42.08% |
| 2023 | 2023-12-31 | 8.15 | 6.28 | +333.96% |
| 2022 | 2022-12-31 | 1.88 | −2.11 | −52.93% |
| 2021 | 2021-12-31 | 3.99 | — | — |
Coya Therapeutics quarterly current ratio
Q4.21
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 13.40 | 5.97 | +80.40% |
| Q1 2026 | 2026-03-31 | 15.02 | 6.18 | +69.89% |
| Q4 2025 | 2025-12-31 | 8.50 | −3.08 | −26.59% |
| Q3 2025 | 2025-09-30 | 8.73 | −6.58 | −42.96% |
| Q2 2025 | 2025-06-30 | 7.43 | −3.00 | −28.77% |
| Q1 2025 | 2025-03-31 | 8.84 | 0.20 | +2.27% |
| Q4 2024 | 2024-12-31 | 11.59 | 3.43 | +42.08% |
| Q3 2024 | 2024-09-30 | 15.31 | 8.77 | +133.97% |
| Q2 2024 | 2024-06-30 | 10.43 | −1.36 | −11.51% |
| Q1 2024 | 2024-03-31 | 8.64 | −5.04 | −36.84% |
| Q4 2023 | 2023-12-31 | 8.15 | 6.28 | +333.96% |
| Q3 2023 | 2023-09-30 | 6.54 | — | — |
| Q2 2023 | 2023-06-30 | 11.78 | — | — |
| Q1 2023 | 2023-03-31 | 13.69 | — | — |
| Q4 2022 | 2022-12-31 | 1.88 | −2.11 | −52.93% |
| Q4 2021 | 2021-12-31 | 3.99 | — | — |
Coya Therapeutics current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Coya Therapeutics's current ratio increased from 3.99 to 8.50, a change of 4.51. The latest reported quarter, Q2 2026, shows 13.40.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Coya Therapeutics source filings ↗